Status:

RECRUITING

Gait Recovery in Patients After Acute Ischemic Stroke

Lead Sponsor:

University Hospital Olomouc

Collaborating Sponsors:

Palacky University

Conditions:

Ischemic Stroke

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

More than 80% of ischemic stroke (IS) patients have some walking disability, which restricts their independence in the activities of daily living. Physical therapy (PT) significantly contributes to ga...

Detailed Description

One hundred twenty consecutive first ever ischemic stroke patients classified as dependent walkers (Functional Ambulatory Category interval \<1,3\>) will be enrolled in the randomized blinded single c...

Eligibility Criteria

Inclusion

  • Ischemic stroke detected on magnetic resonance imaging (MRI) with NIHSS score 1-12 points at the time of enrolment
  • Lower limb movement impairment with a score of at least 1 point on the NIH Stroke Scale (NIHSS) at the time of enrolment
  • Dependency in walking according to Functional Ambulatory Category (FAC) with score interval \<1,3\> (supervision or assistance, or both, must be given in performing walking)

Exclusion

  • Previous history of any stroke, either ischemic or hemorrhagic
  • Other diseases modifying or limiting walking ability, currently receiving rehabilitation or participation in another study
  • Significant/symptomatic ischemic heart disease or significant/symptomatic peripheral arterial disease
  • Obesity (BMI ≥ 40), or weight higher than 110 kg (weight limit for the robot-assisted gait training)
  • Sensory aphasia with the inability to understand having been verified by a certified speech therapist.
  • Moderate or severe depression present at the time of enrolment assessed using the Beck scale, with a score above 10.
  • Known cognitive impairment
  • Previous disability or dependence in the daily activities assessed using the modified Rankin Scale with a score of 3 and more points
  • Currently receiving dialysis
  • Diagnosed and/or receiving treatment for cancer
  • Presence of other orthopedic or neurological conditions affecting the lower extremities
  • For fMRI: Pregnancy; electronic implants, including cochlear implant, pacemaker, neurostimulator; incompatible metallic implants, including aneurysm clip; metallic intraocular foreign body; large tattoos; unremovable piercing; body weight over 150 kg; known claustrophobia

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04824482

Start Date

September 1 2020

End Date

December 31 2026

Last Update

July 29 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Olomouc

Olomouc, Czechia, 77520